Crocs, Inc.
CROX
$120.64
-3.74%
Crocs, Inc. is a global footwear company known for its distinctive casual lifestyle clogs and sandals, operating within the Consumer Cyclical sector's Apparel - Footwear & Accessories industry. The company has established itself as a resilient brand leader, successfully transitioning from a fad to a durable, fashion-forward comfort brand with a loyal consumer base. The current investor narrative is sharply divided between optimism for the core Crocs brand's continued strength and concerns over the integration and performance of its HEYDUDE acquisition, with recent news highlighting analyst upgrades based on brand recovery and valuation, while also noting the HEYDUDE segment remains a significant overhang impacting sentiment.…
CROX
Crocs, Inc.
$120.64
Related headlines
CROX 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crocs, Inc.'s 12-month outlook, with a consensus price target around $156.83 and implied upside of +30.0% versus the current price.
Average Target
$156.83
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$97 - $157
Analyst target range
Analyst coverage is limited, with only 3 analysts providing estimates, indicating this is a smaller-cap stock with less institutional scrutiny, which can lead to higher volatility. The consensus appears mixed, as reflected in recent institutional actions: while Needham maintains a 'Buy', Stifel and Barclays have 'Hold' or 'Equal Weight' ratings, and Goldman Sachs has a 'Sell', with a notable downgrade from Keybanc to 'Sector Weight' from 'Overweight' in January 2026. The average EPS estimate for the coming period is $14.83, with a range from $14.53 to $15.14, and the average revenue estimate is $4.56 billion, but no explicit price targets are provided in the data, making it impossible to calculate implied upside or downside. The wide dispersion in analyst ratings—from Buy to Sell—and the lack of a clear price target consensus signal high uncertainty and debate regarding the company's ability to successfully integrate the HEYDUDE brand and return to consistent revenue growth, which is a key risk factor for investors.
Bulls vs Bears: CROX Investment Factors
The evidence currently tilts slightly bullish, primarily driven by a deeply discounted valuation, strong core brand profitability, and powerful recent price momentum. However, the bear case is formidable, anchored by concrete revenue declines and the unresolved HEYDUDE integration. The single most important tension in the investment debate is whether the current valuation discount (PS of 1.15) accurately prices in the HEYDUDE-related risks and growth deceleration, or if it represents an overreaction to temporary headwinds given the company's robust cash flow and brand strength. The resolution of this tension—specifically, evidence of HEYDUDE stabilization or a return to revenue growth—will determine the stock's direction.
Bullish
- Strong Core Brand Profitability: The Crocs brand segment continues to generate robust profitability, as evidenced by a solid gross margin of 56.97% and a return to strong quarterly net income of $105.2M in Q4 2025. This demonstrates the underlying health of the core business despite revenue headwinds.
- Extremely Compressed Valuation: The stock trades at a Price-to-Sales (PS) ratio of 1.15, which is near the bottom of its historical range and significantly below its recent highs above 8.0. This deep discount suggests the market is pricing in a worst-case scenario, creating a potential value opportunity if fundamentals stabilize.
- Powerful Technical Momentum: The stock has surged 49.46% over the past three months, significantly outperforming the S&P 500's 15.8% gain. It is trading at 82% of its 52-week high, indicating strong bullish momentum and a potential breakout above the $129.79 resistance level.
- Robust Free Cash Flow Generation: The company generated $659.2M in trailing twelve-month free cash flow, providing ample liquidity. This strong cash generation supports continued share repurchases, as seen with $180.17M in buybacks in Q4 2025, and funds the HEYDUDE turnaround effort.
Bearish
- Revenue Decline & HEYDUDE Overhang: Latest quarterly revenue declined -3.25% YoY to $957.64M, signaling growth challenges. The primary investor debate centers on the struggling HEYDUDE acquisition, which remains a significant overhang on sentiment and operational performance.
- Trailing Net Loss & Impairment: The company reported a trailing net loss with a net margin of -2.01%, heavily impacted by a massive $492.3M quarterly net loss in Q2 2025 due to an impairment charge. This highlights significant asset write-downs and earnings volatility.
- High Volatility & Drawdown Risk: With a beta of 1.557, the stock is 56% more volatile than the market. It has a maximum drawdown potential of -34.95%, indicating significant downside risk during market corrections, as seen from its 52-week low of $73.21.
- Analyst Uncertainty & Lack of Targets: Analyst coverage is limited and deeply divided, with ratings ranging from Goldman Sachs' 'Sell' to Needham's 'Buy'. The lack of explicit consensus price targets reflects high uncertainty about the company's ability to integrate HEYDUDE and return to growth.
CROX Technical Analysis
The stock is in a strong, sustained uptrend, having gained 20.52% over the past year, significantly outperforming the broader market's 20.95% gain as evidenced by its negative 1-year relative strength of -0.43%. As of the latest close, the stock is trading at $118.88, which is approximately 82% of its 52-week range ($73.21 to $129.79), positioning it near the upper end and suggesting strong momentum but also potential for overextension if it approaches the high. The recent short-term momentum is exceptionally strong, with the stock surging 49.46% over the past three months and 2.46% over the past month, significantly outpacing the S&P 500's 15.8% and -2.17% returns for the same periods, indicating accelerating bullish momentum that diverges positively from the longer-term trend. Key technical support is anchored at the 52-week low of $73.21, while immediate resistance sits at the 52-week high of $129.79; a decisive breakout above this level could signal a continuation of the powerful uptrend, while a failure could lead to a consolidation phase. With a beta of 1.557, the stock exhibits approximately 56% more volatility than the market, which is a critical consideration for risk management, especially given the stock's 34.95% maximum drawdown potential during corrections.
Beta
1.56
1.56x market volatility
Max Drawdown
-33.3%
Largest decline past year
52-Week Range
$73-$130
Price range past year
Annual Return
+19.1%
Cumulative gain past year
| Period | CROX Return | S&P 500 |
|---|---|---|
| 1m | +1.7% | -1.3% |
| 3m | +44.4% | +14.0% |
| 6m | +41.1% | +9.5% |
| 1y | +19.1% | +20.9% |
| ytd | +38.7% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CROX Fundamental Analysis
Revenue growth has recently decelerated, with the latest quarterly revenue of $957.64 million representing a -3.25% year-over-year decline, a stark contrast to the robust growth seen in prior periods, indicating potential headwinds from the HEYDUDE integration or market saturation. The company remains profitable on an operating basis with a solid gross margin of 56.97%, but reported a net loss for the trailing period with a net margin of -2.01%, heavily impacted by a significant impairment or one-time charge in Q2 2025 that resulted in a quarterly net loss of -$492.28 million, though subsequent quarters (Q3 and Q4 2025) showed a return to strong profitability with net income of $145.82 million and $105.17 million, respectively. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.25, but the company generates robust cash flow, evidenced by a trailing twelve-month free cash flow of $659.2 million, providing ample liquidity to fund operations and share repurchases, as seen with $180.17 million in buybacks in Q4 2025, though the current ratio of 1.27 indicates adequate but not excessive short-term liquidity.
Quarterly Revenue
$957640000.0B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.54%
Latest Quarter
Free Cash Flow
$659200000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CROX Overvalued?
Given the trailing twelve-month net income is negative, we lead with the Price-to-Sales (PS) ratio for valuation, which stands at 1.15. This PS ratio is significantly below the stock's own historical average seen in recent quarters (e.g., 4.59 in Q4 2025 and 6.36 in Q1 2025), suggesting a substantial compression in the sales multiple. Compared to typical footwear and apparel peers, a PS ratio around 1.1 appears discounted, though this likely reflects market skepticism around growth and the HEYDUDE segment's challenges rather than a pure value opportunity. Historically, the stock's valuation has fluctuated wildly; the current PS of 1.15 is near the bottom of its recent historical range (from above 8.0 in mid-2024 to as low as 1.15 now), indicating the market may be pricing in a scenario of stagnant growth or fundamental deterioration, creating a potential value opportunity if the company's turnaround plans for HEYDUDE gain traction.
PE
-57.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -3x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Crocs faces significant financial risk from earnings volatility, as demonstrated by the massive $492.3M net loss in Q2 2025 due to an impairment charge, which drove the trailing net margin to -2.01%. While subsequent quarters showed profitability, this event underscores balance sheet risks related to the HEYDUDE acquisition. Revenue concentration is another concern, with the Crocs brand as the primary driver; the recent -3.25% YoY revenue decline indicates vulnerability to market saturation or brand fatigue. Although the company has a manageable debt-to-equity ratio of 1.25 and strong free cash flow of $659.2M, its valuation is highly dependent on a return to growth, making it sensitive to any further earnings misses.
Market & Competitive Risks: The stock's primary market risk is valuation compression, as its current PS ratio of 1.15 is a fraction of its historical multiples, suggesting the market has already severely de-rated the stock. However, with a beta of 1.56, it remains highly sensitive to broader market downturns, which could trigger further selling. Competitive disruption is a constant threat in the fast-moving footwear industry, and the HEYDUDE segment's struggles highlight execution risk in brand portfolio expansion. Recent news consistently cites HEYDUDE as an overhang, indicating that negative sentiment on this front could persist and limit multiple expansion even if the core brand performs well.
Worst-Case Scenario: The worst-case scenario involves a failure to stabilize the HEYDUDE brand, leading to further write-downs, combined with a recessionary consumer environment that pressures the core Crocs brand's sales and margins. This could trigger a loss of investor confidence, analyst downgrades, and a re-test of the 52-week low of $73.21. Given the stock's high volatility, such a scenario could materialize rapidly. From the current price of $118.88, this represents a realistic downside of approximately -38.5%. A sustained period of revenue decline could see the PS ratio compress even further from its already depressed level, exacerbating losses.